Tag
Rainbow Children's Medicare Limited
4 articles
Rainbow Children's Medicare Board Approves FY26 Results, Dividend, Director Reappointments
Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, with unmodified audit opinion.
Recommended a final dividend of ₹3.5 per equity share (35%) for
Rainbow Children's Medicare Q4 PAT Up 38% YoY
Rainbow Children's Medicare reported Q4 FY26 consolidated revenue of ₹4,599 Mn, up 24% YoY, with PAT surging 38% to ₹782.2 Mn.
The company expanded its network to 2,435 beds across 24 hospitals, addin
Rainbow Children's Q4 PAT Up 38.3% YoY
Rainbow Children's Medicare reported Q4 FY26 revenue of ₹4,599 million, up 24.3% YoY, with PAT growing 38.3% to ₹782 million.
The company completed its capacity expansion cycle, adding new facilities
Rainbow Children's Medicare FY26 Results, Dividend, Director Reappointments
Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026 with unmodified audit opinion.
Recommended final dividend of ₹3.5 per share (35%) for FY26, subj